Roche Holding AG
Rating
Updated: Sep 17, 2026Why Price Moved
Shares are trading higher after Lunsumio combo met...
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
A detailed description of the company is not yet available.
Latest News
5 days ago · zacks.com
RHHBY's Lunsumio Combo Meets Goal in 2L Follicular Lymphoma StudyRoche's Lunsumio-Revlimid combo meets its study goal in second-line or later follicular lymphoma, improving PFS versus rituximab plus Revlimid.
12 days ago · zacks.com
AMGN, AZN Drug Combo Shows Survival Benefit in Lung Cancer StudyAmgen and AstraZeneca's Imdelltra-Imfinzi combo shows survival benefits in first-line ES-SCLC, potentially broadening both drugs' reach.
12 days ago · zacks.com
Roche Gets FDA Priority Tag for Enspryng in Rare Autoimmune DisorderRHHBY's sBLA for Enspryng wins FDA priority tag for myelin oligodendrocyte glycoprotein antibody-associated disease. A decision is due on Jan. 10, 2027.
21 days ago · reuters.com
Roche signs global licensing pact for Simcere's experimental blood cancer drugSwitzerland's Roche will pay $75 million upfront to Simcere Pharmaceutical Group for rights to an experimental blood cancer drug, the Chinese drugmaker said Tuesday.
21 days ago · youtube.com
U.S.' 'win' in the war has been choking off Iran's oil exports: David RocheDavid Roche of Quantum Strategy says oil flows out of the Strait of Hormuz are likely to be far lower than what the U.S. claims. He adds that while Washington's economic pressure on Tehran is growing, it's unlikely to change Iran's strategy of wanting to control the Strait of Hormuz.
26 days ago · zacks.com
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track NowFDA clearance of Lilly and Roche's Alzheimer's blood test highlights a growing diagnostics market and four healthcare ETFs to watch.
29 days ago · forbes.com
FDA Clears Roche And Eli Lilly's Alzheimer's Blood TestThe Food and Drug Administration has cleared a new blood test from Roche and Eli Lilly designed to help identify symptoms related to Alzheimer's disease in patients over age 55, Roche said on Monday morning.
29 days ago · wsj.com
FDA Approves Alzheimer's Blood Test Developed by Roche and Eli LillyThe Food and Drug Administration cleared a blood test for identifying Alzheimer's disease symptoms, which was developed by Roche and Eli Lilly.
29 days ago · reuters.com
Roche, Eli Lilly's Alzheimer's blood test gets FDA clearanceThe U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood test to help identify signs of Alzheimer's disease in people aged 55 and older with cognitive decline.
1 month ago · marketbeat.com
Recursion Pharmaceuticals Highlights AI Platform, Roche Progress and Pipeline UpdatesRecursion Pharmaceuticals NASDAQ: RXRX is using artificial intelligence to generate and analyze biological data in an effort to improve drug discovery, advance internal therapeutic programs and support collaborations with larger pharmaceutical companies, CFO and President of Recursion U.K. Ben Taylor said during a BofA Global Research virtual conference.
Add to Watchlist
Select watchlists to add or remove RHHVF